Delayed Administration of Pyroglutamate Helix B Surface Peptide (pHBSP), a Novel Nonerythropoietic Analog of Erythropoietin, Attenuates Acute Kidney Injury

In preclinical studies, erythropoietin (EPO) reduces ischemia-reperfusion–associated tissue injury (for example, stroke, myocardial infarction, acute kidney injury, hemorrhagic shock and liver ischemia). It has been proposed that the erythropoietic effects of EPO are mediated by the classic EPO rece...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Patel, Nimesh S A, Kerr-Peterson, Hannah L, Brines, Michael, Collino, Massimo, Rogazzo, Mara, Fantozzi, Roberto, Wood, Elizabeth G, Johnson, Florence L, Yaqoob, Muhammad M, Cerami, Anthony, Thiemermann, Christoph
Formato: Artigo
Idioma:Inglês
Publicado em: ScholarOne 2012
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3388125/
https://ncbi.nlm.nih.gov/pubmed/22415011
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2012.00093
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados